ABDOMINAL OBESITY IN ARTERIAL HYPERTENSION: ATHEROGENIC ALTERATIONS IN LIPID TRANSPORT SYSTEMS AND CARBOHYDRATES METABOLISM

The comparative analysis of CHD risk factors which are known metabolic syndrome components was conducted in groups of patients with arterial hypertension (AH) combined with abdominal obesity (AO), in hypertensive subjects with normal body mass index, and in those with AH, AO and glucose intolerance....

Full description

Bibliographic Details
Main Authors: R. G. Oganov, N. N. Perova, V. A. Metelskaya, A. M. Olferev, M. N. Mamedov, L. A. Ratnikova, N. V. Sheltsina, O. E. Melkina, I. E. Petrichenko
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2001-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2037
Description
Summary:The comparative analysis of CHD risk factors which are known metabolic syndrome components was conducted in groups of patients with arterial hypertension (AH) combined with abdominal obesity (AO), in hypertensive subjects with normal body mass index, and in those with AH, AO and glucose intolerance. The combination of AH with AO was coupled with higher SBP and DBP, and with more pronounced atherogenic shifts in lipoprotein profile: elevated levels of triglycerides, total cholesterol, apo B and apoB/AI ratio. The magnitude of these parameters was closed to that in group with AH, AO and glucose intolerance; hyperlipidemia in the last group was aggravated by decreased HDL cholesterol level. Patients with AH and AO had significantly higher blood insulin level and lower glucose/insulin ratio than subjects with AH only. These results might indicate the existence of latent insulin resistance in hypertensive patients with abdominal (visceral) obesity. Global CHD risk for these patients appeared to be higher than in subjects with AH only.
ISSN:1560-4071
2618-7620